AGM/EGMApr 30, 2026, 04:43 PM
INKT Annual Meeting June 17; Director Elections, Auditor Ratification
AI Summary
MiNK Therapeutics, Inc. filed its definitive proxy statement for its Annual Meeting of Stockholders to be held virtually on June 17, 2026. Stockholders of record as of April 23, 2026, are entitled to vote on proposals including the election of three Class II directors (Garo Armen, Barbara Ryan, and John Holcomb) and the ratification of KPMG LLP as the independent registered public accounting firm for fiscal year 2026. The company's Board of Directors consists of seven members, with five identified as independent.
Key Highlights
- MiNK Therapeutics to hold Annual Meeting of Stockholders on June 17, 2026.
- Stockholders of record as of April 23, 2026, are eligible to vote.
- Proposals include electing Garo Armen, Barbara Ryan, and John Holcomb as Class II directors.
- Proposal to ratify KPMG LLP as independent auditor for fiscal year 2026.
- Board of Directors comprises 7 members, with 5 identified as independent.
- Company effected a 1-for-10 reverse stock split on January 28, 2025.
- 4,981,899 shares of common stock outstanding as of the record date.
Price Impact
More from INKT